GLUCOCORTICOIDS, HYPOGLYCEMIA & BRAIN GLUCOSE TRANSPORT
糖皮质激素,低血糖
基本信息
- 批准号:6074968
- 负责人:
- 金额:$ 21.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assay brain metabolism cerebral cortex corticosterone gene expression glucose transport glucose transporter hippocampus hormone regulation /control mechanism hypoglycemia hypothalamus immunocytochemistry in situ hybridization insulin laboratory rabbit laboratory rat messenger RNA metyrapone pathologic process stress western blottings
项目摘要
Hypoglycemia is the barrier to excellent glycemic control for many patients with diabetes, especially those with Type 1 diabetes. The inability to perceive hypoglycemia, hypoglycemia unawareness, and the inability to mount a protective counter- insulin hormonal defense--- defective counterregulation--- are the most important risk factors for repeated and serious hypoglycemia in those with diabetes. Recent evidence from several differing lines of investigation suggest a common hormonal mechanism affecting the brain could underlie much of hypoglycemia unawareness and defective counterregulation. First, glucocorticoid stress hormones may be important in inducing hypoglycemia unawareness and defective counterregulation. Second, transport of nutrient glucose into brain cells may also underlie these two interrelated phenomena. Third, certain key areas of the brain, in particular the ventromedial hypothalamus and hippocampus, may be involved in the defective signal transduction that underlies hypoglycemia unawareness and defective counterregulation. Fourth, preliminary work shows that glucocorticoids modify brain glucose transporter expression. Thus, the studies proposed will test the hypothesis that hypoglycemia induces glucocorticoid stress hormones and that by doing so, these hormones help to alter brain glucose transport and metabolism in key areas of the brain that are a major basis for subsequent, defective counter-insulin protective hormonal responses. This project's specific aims are to: 1. Determine how mild and more marked stress levels of corticosterone administered to rats affect regional expression of brain GLUT1 and GLUT3 protein and mRNA. 2. Determine how repeated hypoglycemia affects regional brain GLUT1 and GLUT3 protein and mRNA expression. 3. Determine how stress levels of corticosterone administered to rats and chronic insulin hypoglycemia affect hypoglycemia-induced stress responses. 4. Determine how pharmacological blockade of glucocorticoid secretion after insulin hypoglycemia affects brain expression of GLUT1 and GLUT3 and hypoglycemia counterregulation. We will test whether the ventromedial hypothalamus and hippocampal formation, in particular, are subject to regulation of brain glucose transport proteins as a result of chronic hypoglycemia and glucocorticoid excess. With high affinity antibodies suitable for fine immunocytochemical localization, our lab is uniquely able to assess precise anatomic localization of brain glucose transporter changes. We will assess in rats the counterregulation response to a single bout of hypoglycemia after prior chronic hypoglycemia. We will test whether glucocorticoid treatment induces similar defective counterregulation after hypoglycemia. Finally, we will assess whether blockade of hypoglycemia induced glucocorticoid excess may prevent altered brain GLUT expression in these key areas and thereby prevent defective counterregulation responses to acute hypoglycemia. These studies should provide insight into hypoglycemia's impact upon the brain. They may potentially lead to safer was to achieve good diabetes control.
低血糖是许多糖尿病患者,特别是1型糖尿病患者良好血糖控制的障碍。不能察觉低血糖,不知道低血糖,以及无法建立保护性的反胰岛素激素防御-有缺陷的反调节-是糖尿病患者反复发生严重低血糖的最重要的危险因素。最近来自几个不同研究方向的证据表明,影响大脑的一种共同的荷尔蒙机制可能是低血糖、意识不清和反调节缺陷的主要原因。首先,糖皮质激素应激激素可能是导致低血糖意识不清和反调节缺陷的重要因素。其次,营养葡萄糖向脑细胞的运输也可能是这两个相互关联的现象的基础。第三,大脑的某些关键区域,特别是下丘脑腹内侧和海马体,可能参与了导致低血糖意识和反调节缺陷的信号转导缺陷。第四,初步研究表明,糖皮质激素可以改变大脑葡萄糖转运蛋白的表达。因此,提出的研究将检验这样一个假设,即低血糖诱导糖皮质激素应激激素,并且通过这样做,这些激素有助于改变大脑关键区域的葡萄糖运输和新陈代谢,这是随后有缺陷的抗胰岛素保护性激素反应的主要基础。本项目的具体目标是:1.确定给予大鼠轻度和较明显的皮质酮应激水平如何影响大脑GLUT1和GLUT3蛋白和mRNA的区域表达。2.确定反复低血糖对局部脑GLUT1和GLUT3蛋白和mRNA表达的影响。3.确定给予大鼠皮质酮的应激水平和慢性胰岛素低血糖如何影响低血糖诱导的应激反应。4.确定药物阻断胰岛素低血糖后糖皮质激素分泌对脑内GLUT1和GLUT3表达的影响以及低血糖的反调节作用。我们将测试由于慢性低血糖和糖皮质激素过量,特别是下丘脑腹内侧和海马结构是否受到大脑葡萄糖运输蛋白的调节。凭借适合精细免疫细胞化学定位的高亲和力抗体,我们的实验室唯一能够评估大脑葡萄糖转运蛋白变化的精确解剖定位。我们将在大鼠中评估在既往慢性低血糖后单次低血糖的反调节反应。我们将测试糖皮质激素治疗是否会在低血糖后引起类似的缺陷反调节。最后,我们将评估阻断糖皮质激素过量引起的低血糖是否可以防止这些关键区域大脑过度表达的改变,从而防止对急性低血糖的有缺陷的反调节反应。这些研究应该能深入了解低血糖对大脑的影响。它们可能导致更安全的是实现良好的糖尿病控制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANTHONY L MCCALL其他文献
ANTHONY L MCCALL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANTHONY L MCCALL', 18)}}的其他基金
Using Patient Simulation to Optimize Hospital Insulin Infusion in Cardiac Surgery
使用患者模拟优化心脏手术中的医院胰岛素输注
- 批准号:
8624190 - 财政年份:2014
- 资助金额:
$ 21.01万 - 项目类别:
VASCULAR DYSFUNCTION IN DIABETES: GENES AND HORMONES
糖尿病血管功能障碍:基因和激素
- 批准号:
8167181 - 财政年份:2010
- 资助金额:
$ 21.01万 - 项目类别:
VASCULAR DYSFUNCTION IN DIABETES: GENES AND HORMONES
糖尿病血管功能障碍:基因和激素
- 批准号:
7951508 - 财政年份:2009
- 资助金额:
$ 21.01万 - 项目类别:
GLUCOCORTICOIDS, HYPOGLYCEMIA & BRAIN GLUCOSE TRANSPORT
糖皮质激素,低血糖
- 批准号:
6590245 - 财政年份:1999
- 资助金额:
$ 21.01万 - 项目类别:
GLUCOCORTICOIDS, HYPOGLYCEMIA & BRAIN GLUCOSE TRANSPORT
糖皮质激素,低血糖
- 批准号:
6178641 - 财政年份:1999
- 资助金额:
$ 21.01万 - 项目类别:
SYMPOSIUM ON THE CENTRAL NERVOUS SYSTEM AND DIABETES
中枢神经系统与糖尿病研讨会
- 批准号:
3436166 - 财政年份:1991
- 资助金额:
$ 21.01万 - 项目类别:
相似海外基金
Brain metabolism across the lifespan using multi-parametric MRS
使用多参数 MRS 分析整个生命周期的脑代谢
- 批准号:
10738647 - 财政年份:2023
- 资助金额:
$ 21.01万 - 项目类别:
Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging
量化基于任务的 BOLD 成像背后的大脑代谢
- 批准号:
10432379 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
Novel 10.5 T deuterium-based MRS/I method to measure brain metabolism
测量脑代谢的新型 10.5 T 氘 MRS/I 方法
- 批准号:
10442075 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
Neuroimaging study of the effects of phospholipase A2 (PLA2) inhibition on brain metabolism and neuroinflammation in a rat model of Alzheimer’s Disease.
神经影像学研究磷脂酶 A2 (PLA2) 抑制对阿尔茨海默病大鼠模型脑代谢和神经炎症的影响。
- 批准号:
486273 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
Studentship Programs
Dynamics of Cellular Brain Metabolism Using Mass Spectrometry Imaging
使用质谱成像研究细胞脑代谢动力学
- 批准号:
10556434 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
In vivo MRI Measures of Brain Metabolism in Traumatic Brain Injury
创伤性脑损伤中脑代谢的体内 MRI 测量
- 批准号:
10444479 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging
量化基于任务的 BOLD 成像背后的大脑代谢
- 批准号:
10816746 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
Dynamics of cellular brain metabolism using mass spectrometry imaging
使用质谱成像研究细胞脑代谢动力学
- 批准号:
10418219 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
PhytoSERM 预防更年期相关脑代谢和认知能力下降的功效:双盲、随机、安慰剂对照 2 期临床试验
- 批准号:
10560591 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
Brain metabolism during task-evoked and spontaneous activity in aging and Alzheimer's disease
衰老和阿尔茨海默病中任务诱发和自发活动期间的大脑代谢
- 批准号:
10585419 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:














{{item.name}}会员




